dairy power inline heavy duty alkali cleaner-low foam
ecolab pty ltd - non-ionic detergents; sodium hydroxide - soluble powder - non-ionic detergents emulsifiers & surfactants-noni active 9.0 g/kg; sodium hydroxide mineral-sodium-base active 800.0 g/kg - dairy cleanser - dairy equipment stainless steel | dairy plant stainless steel | building - residue, dirt in milking equipment
dairy chem alkali powder detergent
dubois chemicals australia pty ltd - nonyl phenol ethoxylate; sodium hydroxide - powder - nonyl phenol ethoxylate emulsifiers & surfactants-noni active 10.0 g/kg; sodium hydroxide mineral-sodium-base active 800.0 g/kg - dairy cleanser - dairy equipment - residue, dirt in milking equipment
sodium valproate wockhardt sodium valproate 1000 mg/10 ml solution for injection ampoule
wockhardt bio pty ltd - sodium valproate, quantity: 1000 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - sodium valproate wockhardt is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.
sodium valproate wockhardt sodium valproate 400 mg/4 ml solution for injection ampoule
wockhardt bio pty ltd - sodium valproate, quantity: 400 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - sodium valproate wockhardt is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.
sodium chloride 0.9 % intravenous infusion bp
teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.
sodium chloride 0.9 % intravenous infusion bp
teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.
sodium salicyl 80 % wsp 800 mg/g sol. buv. (pdr.) pot
dopharma (research) n.v. - salicylate de sodium 800 mg/g - eq. acide salicylique 690 mg/g - poudre pour solution buvable - 800 mg/g - salicylate de sodium 800 mg/g - sodium salicylate - bovin; porc
hope pharmaceuticals sodium thiosulfate injection sodium thiosulfate pentahydrate12.5 g/50 ml solution for injection vial
hope pharmaceuticals pty ltd - sodium thiosulfate pentahydrate, quantity: 12.5 g - solution - excipient ingredients: water for injections; potassium chloride; boric acid; sodium hydroxide - hope pharmaceuticals sodium thiosulfate injection is indicated as an antidote in the treatment of cyanide poisoning. it is frequently used in conjunction with sodium nitrite.,sodium thiosulfate is also indicated to prevent sodium nitroprusside induced cyanide poisoning.
dbl sodium thiosulfate injection sodium thiosulfate pentahydrate 2.5g/10ml solution for injection vial
pfizer australia pty ltd - sodium thiosulfate pentahydrate, quantity: 2.5 g - injection, solution - excipient ingredients: sulfuric acid; sodium metabisulfite; dibasic sodium phosphate dodecahydrate; water for injections; sodium hydroxide - dbl sodium thiosulfate injection is indicated as an antidote in the treatment of cyanide poisoning. it is frequently used in conjunction with sodium nitrite. sodium thiosulfate is also indicated to prevent sodium nitroprusside induced cyanide poisoning.
eplerenone cristers 25 mg, comprimé pelliculé
cristers - éplérénone 25 mg - comprimé - 25 mg - pour un comprimé > éplérénone 25 mg - antagoniste de l’aldostérone - eplerenone cristers appartient à un groupe de médicaments connus comme agents de blocage sélectifs de l'aldostérone. ces agents de blocage inhibent l'action de l'aldostérone, une substance produite dans le corps, qui contrôle votre tension artérielle et votre fonction cardiaque. un taux élevé d'aldostérone peut provoquer des modifications dans votre corps qui mènent à une insuffisance cardiaque.eplerenone cristers est utilisé pour traiter votre insuffisance cardiaque afin de prévenir toute aggravation et réduire les hospitalisations si : vous avez eu une crise cardiaque récente, en association avec d'autres médicaments qui sont utilisés pour traiter votre insuffisance cardiaque, vous avez des symptômes légers et persistants, malgré le traitement que vous avez reçu à ce jour.